Joost Peerbooms

31 Concentrations of blood components in PRP separation systems 18. Everts P, Devilee R, Brown Mahoney C, et al. Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome: a prospective randomized double-blind study. Eur Surg Res. 2008; 40(2): 203-10. 19. Filardo G, Di Matteo B, Kon E, et al. Platelet-rich plasma in tendon-related disorders: results and indications. Knee Surg Sports Traumatol Arthrosc. 2016; doi:10.1007/s00167-016-4261-4. 20. Fitzpatrick J, Bulsara M, Zheng M. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. Am J Sports Med. 2017; 45(1): 226-33. 21. Foster T, Puskas B, Mandelbaum B, et al. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009; 37: 2259-72. 22. Gentile P, Cervelli V. Use of platelet-rich plasma in maxillofacial surgery. J Craniofac Surg. 2012; 23(5): 1580-82. 23. Gosens T, Peerbooms J, van Laar W, den Oudsten B. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011; 39(6): 1200-08. 24. Hamilton B, Tol J, Knez W, et al. Exercise and the platelet activator calcium chloride both influence the growth factor content of platelet-rich plasma (PRP): overlooked biochemical factors that could influence PRP treatment. Br J Sports Med. 2015; 49(14): 957-60. 25. Howard D, Shepherd J, Kew S, et al. Release of growth factors from a reinforced collagen GAG matrix supplemented with platelet rich plasma: influence on cultured human meniscal cells. J Orthop Res. 2014; 32(2): 273-78. 26. Kaux J, Le Goff C, Renouf J, et al. Comparison of the platelet concentrations obtained in platelet-rich plasma (PRP) between the GPS II and GPS III systems. Pathol Biol (Paris). 2011; 59(5): 275-77. 27. Kaux J, Le Goff C, Seidel L, et al. Comparative study of five techniques of preparation of platelet-rich plasma. Pathol Biol (Paris). 2011; 59(3): 157-60. 28. Kobayashi Y, Saita Y, Nishio H, et al. Leukocyte concentration and composition in platelet- rich plasma (PRP) influences the growth factor and protease concentrations. J Orthop Sci. 2016; 21(5): 683-89. 29. Kushida S, Kakudo N, Morimoto N, et al. Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems. J Artif Organs. 2014; 17(2): 186-92. 30. Leitner G, Gruber R, Neumuller J, et al. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems. Vox Sang. 2006; 91(2): 135-39. 31. Lisi C, Perotti C, Scudeller L, et al. Treatment of knee osteoarthritis: platelet-derived growth factors vs. hyaluronic acid. A randomized controlled trial. Clin Rehabil. 2018; 32(3): 330-39. 32. Magalon J, Bausset O, Serratrice N, et al. Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthroscopy. 2014; 30(5): 629-38. 33. Martinez-Zapata M, Martí-Carvajal A, Sola I, et al. Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst Rev. 2016; (5): CD006899. 34. Marx R. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001; 10: 225-28. 2